de Ponthaud, Charles
Abdalla, Solafah
Belot, Marie-Pierre
Shao, Xiaojian
Penna, Christophe
Brouquet, Antoine
Bougnères, Pierre
Article History
Received: 20 June 2023
Accepted: 18 January 2024
First Online: 14 February 2024
Change Date: 18 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13148-024-01654-6
Declarations
:
: The research protocol in the Dept of Surgery was reviewed and approved by Paris Sud University IRB. in accordance with the French regulations. During the pre-operative consultation, participants provided written informed consent to participate. Additional consent to review medical records and for genetic analysis was obtained through signed written consent.
: Not applicable.
: P.Bougnères is the scientific founder of Adrenas Therapeutics, which had no role in this research. MPB is an employee of Therapy Design Consulting who gave technical advice to CdP at initiation of the study.